Mobile Menu - OpenMobile Menu - Closed


Larson Works to Lower Prescription Drug Prices

October 17, 2019
Press Release

Washington, D.C. – Today, Rep. John B. Larson (CT-01) advocated for lower prescription drug prices at the Ways and Means Committee hearing, Investing in the U.S. Health System by Lowering Drug Prices, Reducing Out-of-Pocket Costs, and Improving Medicare Benefits.

“Almost every American has either found a prescription drug to be unaffordable for themselves or for a loved one. An 88 year old woman from Connecticut who has COPD wrote in to me and said: ‘As of Jan 1 the cost for my Tudorza pressair inhaler will be $1,266 per month!  I use it 2x daily. There is no equivalent prescription on the formulary. This is more than my monthly Social Security income. . . . Do I have to lose my rent or stop eating in order to continue breathing?’

“This is not how it should be. That’s why I’m proud to work with my colleagues on HR 3, The Lower Drug Costs Now Act. In addition to lowering costs, this legislation also caps the out of pocket patient drug expenses in Medicare. The time to act is now, the American people can’t wait any longer.”

Larson is a cosponsor of HR 3, The Lower Drug Costs Now Act. He also is one of the lead sponsors of the Medicare Buy-In at 50, which would also allow Medicare to negotiate directly with drug companies.